CONTACT
+91 80 2808 2808
ContactUs.BBL@biocon.com
Biocon Biologics  /  About Us  /  Board of Directors  /  Daniel Bradbury

Daniel Bradbury

Independent Director

Daniel Bradbury

Daniel Bradbury

Independent Director

Year of birth: 1961
Nationality: U.S.

Professional Experience

  • Executive Chairman, former CEO and Co-Founder of Equillium Inc., a company developing products to treat severe autoimmune and inflammatory disorders
  • Managing Member, BioBrit LLC
  • Member, Board of Trustees, Keck Graduate Institute, U.S.
  • Director, Intercept Pharmaceuticals and several private companies and philanthropic organizations
  • Board Chairman, Castle Biosciences Inc & Biolinq
  • Member, Advisory Council, Rady School of Management, San Diego, U.S.
  • Life sciences executive with over 38 years of experience in creating and implementing strategies and transforming businesses
  • Former CEO, Amylin Pharmaceuticals, a leading metabolic disease company, acquired by Bristol Myers Squibb in 2012

Recognitions

  • Recipient of Director of the Year Award from Corporate Directors Forum (2012)
  • EY’s Entrepreneur of the Year Finalist (2012)

Education

  • International Executive Program, INSEAD, France
  • Diploma in Management Studies, Harrow and Ealing Colleges of Higher Education, UK
  • Bachelor of Pharmacy, Nottingham University, UK
Share